{
    "text": "This study demonstrates that SOS1 mutations found in lung adenocarcinoma are oncogenic and that MEK inhibition may be a therapeutic avenue for the treatment of SOS1-mutant cancers.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "gene", 
            "span": {
                "begin": 29, 
                "end": 33
            }
        }, 
        {
            "id": "T2", 
            "obj": "disease", 
            "span": {
                "begin": 53, 
                "end": 72
            }
        }, 
        {
            "id": "T3", 
            "obj": "gene", 
            "span": {
                "begin": 96, 
                "end": 99
            }
        }, 
        {
            "id": "T4", 
            "obj": "disease", 
            "span": {
                "begin": 160, 
                "end": 179
            }
        }
    ], 
    "relations": [
        {
            "id": "R1", 
            "pred": "therapeutic", 
            "subj": "T1", 
            "obj": "T2"
        },
        {
            "id": "R2", 
            "pred": "therapeutic", 
            "subj": "T3", 
            "obj": "T4"
        }
    ]
}